SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREN14A - Non-management preliminary proxy statements:
SEC Accession No. 0001193125-14-220830
Filing Date
2014-06-02
Accepted
2014-06-02 07:48:16
Documents
1
Period of Report
2014-06-02

Document Format Files

Seq Description Document Type Size
1 PREN14A d737831dpren14a.htm PREN14A 594619
  Complete submission text file 0001193125-14-220830.txt   596123
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREN14A | Act: 34 | File No.: 001-10269 | Film No.: 14882146
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREN14A